Browse by Journal Title

2008

In vitro and in vivo evaluation of doxorubicin conjugates with the divalent peptide E-[c(RGDfK)2] that targets integrin alphavbeta3.
Ryppa, C., Mann-Steinberg, H., Fichtner, I., Weber, H., Satchi-Fainaro, R., Biniossek, M.L. and Kratz, F.
Bioconjugate Chemistry 19 (7): 1414-1422. July 2008

2007

Development of albumin-binding camptothecin prodrugs using a peptide positional scanning library.
Schmid, B., Warnecke, A., Fichtner, I., Jung, M. and Kratz, F.
Bioconjugate Chemistry 18 (6): 1786-1799. November 2007

Albumin-Binding Prodrugs of Camptothecin and Doxorubicin with an Ala-Leu-Ala-Leu-Linker That Are Cleaved by Cathepsin B: Synthesis and Antitumor Efficacy.
Schmid, B., Chung, D.E., Warnecke, A., Fichtner, I. and Kratz, F.
Bioconjugate Chemistry 18 (3): 702-716. May 2007

2004

Synthesis and biological activity of water-soluble maleimide derivatives of the anticancer drug Carboplatin designed as albumin-binding prodrugs.
Warnecke, A., Fichtner, I., Garmann, D., Jaehde, U. and Kratz, F.
Bioconjugate Chemistry 15 (6): 1349-1359. 1 November 2004